NUS Stock Recent News
NUS LATEST HEADLINES
Nu Skin (NUS) benefits from its product launches and Nu Vision 2025 strategy amid challenges like cost inflation and currency volatility.
This isn't your grandmother's environment for growing an MLM company. How long can Net Margins be sustained with declining Gross Margins and Operating Margins?
Nu Skin (NUS) bears the brunt of COVID-related disruptions, unfavorable currency movements and global inflation.
Nu Skin (NUS) reported earnings 30 days ago. What's next for the stock?
Nu Skin (NUS) delivered earnings and revenue surprises of 67.92% and 3.94%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
NU Skin Enterprises, Inc. (NYSE:NUS ) Q4 2022 Earnings Conference Call February 15, 2023 5:00 PM ET Company Participants Scott Pond - VP, IR Ryan Napierski - President, CEO & Director Connie Tang - EVP & Chief Global Growth & Customer Experience Officer Mark Lawrence - EVP & CFO Conference Call Participants Mark Astrachan - Stifel, Nicolaus & Company Chasen Bender - Citigroup Operator Good day and thank you for standing by. Welcome to the Fourth Quarter 2022 Nu Skin Enterprises Earnings Conference Call.
Shares of Nu Skin Enterprises Inc. NUS, +4.76% dropped more than 9% in the extended session Wednesday after the multilevel marketing company reported mixed fourth-quarter results, beating Wall Street expectations for profit but missing on sales, and guidance also disappointed. Nu Skin earned $57.2 million, or $1.15 a share, in the quarter, swinging from a loss of $9.2 million, or 18 cents a share, in the year-ago quarter.
Nu Skin's (NUS) fourth-quarter results are likely to reflect the adverse impacts of cost inflation and currency translations, whereas a focus on the Nu Vision 2025 strategy is likely to have been an upside.
Our residual valuation model suggests that Nu Skin is overvalued by approximately 50%. Despite re-openings in China, Nu Skin's operations remain exposed to cyclical risks.
Nu Skin (NUS) reported earnings 30 days ago. What's next for the stock?